JP Morgan Chase’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-124,573
Closed -$15.1M 7515
2023
Q1
$15.1M Sell
124,573
-69,899
-36% -$8.04M ﹤0.01% 1902
2022
Q4
$22.3M Buy
194,472
+44,370
+30% +$4.89M ﹤0.01% 1591
2022
Q3
$15.2M Buy
150,102
+13,319
+10% +$1.41M ﹤0.01% 1794
2022
Q2
$13.9M Buy
136,783
+133,354
+3,889% +$14.5M ﹤0.01% 1910
2022
Q1
$399K Sell
3,429
-23,596
-87% -$2.73M ﹤0.01% 4838
2021
Q4
$3.1M Buy
+27,025
New +$3.08M ﹤0.01% 3469
2020
Q4
Sell
-7,626
Closed -$853K 6046
2020
Q3
$853K Buy
7,626
+3,998
+110% +$448K ﹤0.01% 3730
2020
Q2
$380K Buy
+3,628
New +$389K ﹤0.01% 3967

Other funds holding BSX.PRA

JP Morgan Chase's BSX.PRA Position: Q2 2023 in Review

JP Morgan Chase sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 124,573 shares — an estimated $15.1M sold.

JP Morgan Chase first reported a position in BSX.PRA in Q2 2020 and held it in 8 quarters. The position peaked at $22.3M in Q4 2022. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

  • JP Morgan Chase reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
  • JP Morgan Chase sold 124,573 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $15.1M.
  • JP Morgan Chase first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 8 quarters.
  • JP Morgan Chase's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $22.3M in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.